Agfa US Corp

Agfa US Corp, operating through its Agfa Radiology Solutions Division and doing business as Agfa II Acquisition Corp, is a foreign-owned manufacturer of diagnostic imaging equipment and medical supplies that serves as a prime contractor to federal healthcare agencies, with all 496 recent awards held in its own name and no subcontract footprint. The company competes full-and-open on medical equipment and consumables contracts with no set-aside designations across its entire federal portfolio.

Agfa's federal work centers on the design, manufacture, and delivery of radiological and diagnostic imaging systems—digital radiography equipment, X-ray machines, mammography units, portable systems like the DX-D series, consumable imaging media (DRYSTAR film), and preventative and corrective maintenance services supporting military treatment facilities, Department of Veterans Affairs hospitals, and Defense Health Agency operations. Representative prime awards include a $1.5 billion maintenance delivery order from the Defense Logistics Agency Medical Supply Chain (December 2023, DLA Medical Capital Equipment Program IDIQ); a $294.7 million service maintenance agreement for AGFA DX-D100 portable X-ray systems issued by Veterans Integrated Service Network 12 (February 2023, DLA-VA NAC Radiology and Imaging Systems Program); a $252.6 thousand equipment maintenance purchase order from Veterans Integrated Service Network 12 for DX-D100 mobile X-ray systems (August 2026, sole-source, Madison, Wisconsin); and numerous task orders under the DLA Medical Capital Equipment Program and DLA-VA NAC Radiology and Imaging Systems Program for capital equipment delivery and imaging media consumables. Work is performed at Agfa's Greenville, South Carolina headquarters and at performance locations worldwide, including Japan, Italy, Germany, and other overseas military treatment facility and naval medical facility sites.

The Defense Logistics Agency Troop Support Medical dominates Agfa's customer concentration, accounting for 423 awards (85% of recent volume) and $1.48 billion in combined potential value. This concentration is substantially deeper than the next-largest customer: Veterans Integrated Service Network 12 holds only 5 awards but anchors $400.8 million in potential value, reflecting the size of the DX-D100 maintenance contract. The Department of the Navy Pacific Fleet Forces, U.S. Coast Guard, and Defense Health Agency collectively account for 31 awards and $2.1 million in combined potential value. Across 21 distinct customer agencies, Agfa's footprint is heavily concentrated on DLA-sourced procurement for the defense and VA healthcare supply chain.

Agfa sits on two primary parent vehicles: the DLA-VA NAC Radiology and Imaging Systems Program, a government-wide indefinite-delivery/indefinite-quantity contract carrying 341 task orders with $3 million combined potential value, and the DLA Medical Capital Equipment Program, another government-wide IDIQ with 81 task orders and $18.4 million combined potential value. Both vehicles enable recurring task order placement across DoD, VA, Defense Health Agency, and Coast Guard medical operations.

Activity has declined sharply: Agfa held 95 awards in 2022, falling to 74 in 2023, 42 in 2024, 34 in 2025, and only 16 in the first eight months of 2026. This trajectory reflects either slower procurement pipeline velocity or competitive loss on renewal ordering. Fifteen awards (combined potential value $4.2 million) reach ultimate completion inside the next twenty-four months and face recompete exposure. The combined potential value across all 496 awards stands at $1.89 billion, though only $23.5 million (1% of ceiling) has been obligated to date, indicating these are predominantly indefinite-quantity instruments with low near-term cash flow.

Agfa's NAICS footprint is heavily weighted to Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (404 awards), with secondary exposure to Irradiation Apparatus Manufacturing (30 awards). Primary Service Code 80 is Imaging Equipment and Supplies—Medical, Dental, Veterinary (446 awards), followed by maintenance and repair work on medical and veterinary equipment (26 awards). The company manufactures diagnostic imaging equipment domestically and internationally, positions itself as the original equipment manufacturer and sole-source provider for its Agfa-branded systems, and leverages that OEM status to secure sole-source and non-competitive awards for repair, maintenance, upgrades, and consumables on installed federal imaging infrastructure.